EN DE
Watch E for L Aim Public Company Limited for free: we tell you when fair value or trend changes.
Data-driven stock valuation

E for L Aim Public Company Limited (EFORL) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of E for L Aim Public Company Limited stock THB 0.24, price THB 0.10, upside +140.0%, quality 61 out of 100. Rating: strongly undervalued. Calculated from audited financials with 22 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare TH · ISIN TH1001A10Z00

EF E for L Aim Public Company Limited logo Thin data Nov 7, 2026

E for L Aim Public Company Limited

EFORL · BK
Undervalued, but in a downtrend

The stock costs 58% less than our calculation considers fair.

Fair value 0.2400 THB · Strongly undervalued
Quality 61/100
Low debt
Generates free cash flow
Ranks above peers (11/13)
Even on cautious assumptions the value is 80% above the price (0.1800 THB).
Thin margins · 3.6% net margin (TTM)
Weak Growth (revenue 5y −4.8 %/yr in THB)
Narrow moat 37/100 · thin data
Thin data
Watch E for L Aim Public Company Limited for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

2.80 THB 0.0800 THB Fair Value 0.2400 THB May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range 0.0800 THB – 2.80 THB · fair‑value band 0.1800 THB – 0.3100 THB · the 0.1000 THB price screens below the 0.2400 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 7, 2026.

Follow E for L Aim Public Company in your weekly email

Every Wednesday you see whether E for L Aim Public Company is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

E for L Aim Public Company Limited, together with its subsidiaries, engages in the distribution of medical devices and equipment in Thailand, the United States, Europe, and Asia.

Show moreShow less

The company offers medical devices, including patient and central monitor systems, defibrillator, automated external defibrillator, electrocardiographs, electroencephalogram, PSG system, and accessories and consumables, as well as ICU, transport, and MRI ventilators, anesthesia delivery system, incubator and radiant warmer, phototherapy, spirometer, pulmonary function lab, and cardiopulmonary exercise testing devices.

It also provides handheld and ultrasound scanners, high flow oxygen therapy, ceiling pendant, hemodialysis machine, continuous renal replacement therapy, ozone hybrid, patients and medical devices tracking system, MRI infusion and monitor systems, MRI ferrous metal detector, video laryngoscope, hydrogen peroxide plasma sterilizing, and picture archiving and communication devices, as well as clean rooms, anesthesia record system, ECG viewer system, CIS for hemodialysis, telemedicine, telehealth, and PM and after-sale services.

In addition, the company offers diagnosis and laboratory products, such as clinical chemistry, hematology, and immunoassay systems, blood gas and banking, urinalysis, hemoglobin A1C analyzer, automated immunoassay analyzer, rapid test kit, coagulation, POCT clinical chemistry analyzers, air purifier, and laboratory information system.

Further, it distributes microscopes for life sciences comprising educational microscopes, clinical and laboratory microscopes, and microscopes for biological scientific research.

The company was formerly known as Absolute Impact Public Company Limited and changed its name to E for L Aim Public Company Limited in September 2013. E for L Aim Public Company Limited was incorporated in 2005 and is based in Bangkok, Thailand.

Stock analysis

E for L Aim Public Company Limited (EFORL) currently trades at 0.1000 THB, while our model-based Fair Value estimate is 0.2400 THB, implying the stock looks roughly 58% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of 0.2450 THB per share, and 18 of the 22 models we run sit above the 0.1000 THB price.

Bear case: the Asset-Based group reads lowest at 0.0300 THB, and 4 of the 22 models stay below the price. Data coverage for this calculation is low.

Scenario range: 0.1800 THB (bear) to 0.3100 THB (bull), the price of 0.1000 THB sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 61/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.

E for L Aim Public Company Limited reported revenue of 1.3B THB in FY2025 versus 2.2B THB in FY2021, a compound −11.9%/yr. Reported net income was 44.6M THB in FY2025, compounding −51.6%/yr from FY2021.

Key figures

Market cap 400M THB (≈ $12.0M) Micro · P/E ratio 10.0 · P/S ratio 0.34 · EPS (TTM) 0.0100 THB · Net margin 3.6% · Return on equity 7.4% · Return on assets (EBIT) 6.8% (5-year average) · Operating margin 5.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).

What moves the price

The share trades about 38% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 33% fair-value upside, at 140%, EFORL screens cheaper than that median.

Fair Value models

Bear 0.1800 THB Fair Value 0.2400 THB Bull 0.3100 THB
Price 0.1000 THB · Upside +140.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.0086 THB per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF 0.2100 THB 0.2800 THB 0.3900 THB 81
Growth DCF 0.2200 THB 0.2800 THB 0.3800 THB 80
Owner Earnings 0.1800 THB 0.2300 THB 0.3300 THB 77
All 22 models by family
DCF Models
FCF DCF 0.2100 THB 0.2800 THB 0.3900 THB 81
Owner Earnings 0.1800 THB 0.2300 THB 0.3300 THB 77
5Y Revenue Exit 0.1500 THB 0.2000 THB 0.2900 THB 73
5Y EBITDA Exit 0.2200 THB 0.3200 THB 0.4600 THB 75
5Y P/E Exit 0.1700 THB 0.2400 THB 0.3200 THB 71
10Y Revenue Exit 0.1700 THB 0.2100 THB 0.2600 THB 68
10Y EBITDA Exit 0.2100 THB 0.2800 THB 0.3500 THB 70
10Y P/E Exit 0.1900 THB 0.2300 THB 0.2700 THB 65
Earnings-Based
Graham-Dodd 0.0800 THB 0.0900 THB 0.1000 THB 67
EPV 0.0700 THB 0.0900 THB 0.1000 THB 74
Multiples
P/E Multiple 0.1800 THB 0.2500 THB 0.3100 THB 63
P/S Multiple 0.1400 THB 0.1900 THB 0.2400 THB 58
P/B Multiple 0.4800 THB 0.6400 THB 0.8000 THB 55
EV/EBIT 0.1200 THB 0.1800 THB 0.2400 THB 65
EV/EBITDA 0.2200 THB 0.3200 THB 0.4100 THB 67
EV/Revenue 0.0600 THB 0.1200 THB 0.1800 THB 51
Asset-Based
NCAV (Graham) 0.0200 THB 0.0300 THB 0.0400 THB 54
Growth DCF
Growth DCF 0.2200 THB 0.2800 THB 0.3800 THB 80
Rev-Margin DCF 0.1500 THB 0.2100 THB 0.2900 THB 73
Economic Profit
Residual Income 0.1100 THB 0.1200 THB 0.1300 THB 71
ROIC Compounder 0.0700 THB 0.0900 THB 0.1000 THB 72
Growth Earnings
Growth-Adj P/E 0.1300 THB 0.1900 THB 0.2400 THB 68

Open the full fair value analysis →

Quality Score breakdown

Overall quality 61/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 48
How much profit the company makes from its sales and capital
Quality Growth 56
Are margins and returns getting better?
Cashflow 66
Do the profits arrive as real cash?
Financial strength 32
Debt, balance sheet and risk of trouble
Investment 92
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 18
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 7
Distance to the 52-week high, does not count
New shares 82
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−2.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.8%
Start year 2020 (pandemic). Over 10 years: −11.6% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+13.4%
What shareholders gained per year (last 5 years), in THB ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in THB: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
≈ −20.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year−20.0%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−44.9% vs −25.2%, slowing
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−5% → 5%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 11.2%/yr over ~10Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
⚠ Rate on operating basis: 2025 sits 126% above its own trend.

Growth Forecast

Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−6.6%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Thailand: IMF forecast 1.2% a year to 2030, 1.1% from 2016 to 2025) that is about −7.7% a year for the price.

Watch EFORL, get fair value alerts →

Compare E for L Aim Public Company Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 77 stocks

Beats the industry median on 11/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 61 · Top 25%
Fair Value upside +140.0% · Top 25%
Profitability
Return on equity (12 months) 7.4% · Above median
Return on assets 3.6% · Above median
Net margin (12 months) 3.6% · Above median
Operating margin (12 months) 5.2% · Above median
Growth and dividend
Revenue growth (quarter YoY) −28.4% · Bottom 25%
Balance sheet
Debt / equity 0.22× · Above median

Valuation Multiplesvs Medical Distribution median · lower = cheaper

P/E (12 months) 10.0× · Cheapest 25%
P/B 0.69× · Cheapest 25%
P/S (12 months) 0.34× · Cheaper than median
Price / free cash flow (fiscal year) 4.1× · Cheapest 25%
EV/EBITDA 5.3× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 38
FUTURE (revenue growth)0 · sector 24
PAST (return on equity)29 · sector 28
HEALTH (low debt)89 · sector 97
DIVIDEND (yield)0 · sector 54

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Distribution stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Sinopharm Group 1099 HK$17.16 HK$51.48 +200% vs EFORL
Jointown Pharmaceutical Group 600998 ¥5.24 ¥11.56 +121% vs EFORL
Shanghai Pharmaceuticals Holding 601607 ¥16.76 ¥35.78 +113% vs EFORL
China National Medicines Corporation 600511 ¥29.29 ¥58.47 +100% vs EFORL
Guangzhou Baiyunshan Pharmaceutical Holdings 600332 ¥20.09 ¥26.64 +33% vs EFORL
Cencora, Inc COR $333.56 $341.58 +2% vs EFORL
Henry Schein, Inc HSIC $86.05 $78.69 −9% vs EFORL
McKesson Corporation MCK $1,061 $822.74 −22% vs EFORL
Galenica AG GALE CHF 89.45 CHF 61.79 −31% vs EFORL
Cardinal Health, Inc CAH $271.72 $163.14 −40% vs EFORL

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

E for L Aim Public Company Limited: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "E for L Aim Public Company Limited Fair Value". https://www.fairvalue-calculator.com/stock/EFORL

Frequently asked questions

Is E for L Aim Public Company Limited (EFORL) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 0.2400 THB versus a price of 0.1000 THB, about +140% upside (undervalued).
What is the fair value of EFORL?
Our model-based fair value for E for L Aim Public Company Limited is 0.2400 THB (as of Nov 7, 2026), built from audited fundamentals. The current price: 0.1000 THB.
What is the quality score of EFORL?
E for L Aim Public Company Limited has a Quality Score of 61/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for E for L Aim Public Company Limited (EFORL)?
Our model-based price target is the fair value of 0.2400 THB (as of Nov 7, 2026) from 22 valuation models. Cautious scenario 0.1800 THB, optimistic scenario 0.3100 THB. It is a calculation from audited fundamentals, not an analyst target.
What is the E for L Aim Public Company Limited stock forecast for 2026?
Our models put fair value at 0.2400 THB, about +140% upside versus a price of 0.1000 THB (undervalued). Cautious scenario 0.1800 THB, optimistic scenario 0.3100 THB. The calculation is refreshed regularly with new filings.
What is the revenue of E for L Aim Public Company Limited (EFORL)?
E for L Aim Public Company Limited reported trailing-twelve-month revenue of about 1.2B THB (latest available figure, as of Nov 7, 2026).
What growth is priced into E for L Aim Public Company Limited (EFORL)?
For today's price to be fair in a discounted-cash-flow model, E for L Aim Public Company Limited would have to grow free cash flow by -6.6 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew -4.8 % per year. As of Nov 7, 2026.
What discount rate (WACC) does the fair value of EFORL use?
Our models discount E for L Aim Public Company Limited at 11.6 %: a base by market capitalisation (nano), country premium for Thailand. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For E for L Aim Public Company Limited that is -6.6 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has E for L Aim Public Company Limited (EFORL) delivered so far?
Over the past 5 years revenue at E for L Aim Public Company Limited grew -4.8 % a year. The price currently implies free-cash-flow growth of -6.6 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of E for L Aim Public Company Limited (EFORL) growing?
The median revenue growth in the sector is +6.2 % a year. That is the yardstick for the growth priced into E for L Aim Public Company Limited (-6.6 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of E for L Aim Public Company Limited (EFORL)?
The free-cash-flow yield on the price is 24.41 %: that much free cash flow E for L Aim Public Company Limited produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of E for L Aim Public Company Limited (EFORL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For E for L Aim Public Company Limited it is 0.2400 THB per share (as of Nov 7, 2026), against a price of 0.1000 THB. It is the blended result of 22 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is E for L Aim Public Company Limited stock overvalued or undervalued in 2026?
As of Nov 7, 2026, EFORL trades below its calculated fair value: price 0.1000 THB, fair value 0.2400 THB, a gap of about +140% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of EFORL?
No. The price is what the market pays today (0.1000 THB); the fair value is what the company's own numbers justify (0.2400 THB). For E for L Aim Public Company Limited the two are 0.1400 THB per share apart. That gap is exactly why we show both numbers side by side.
How much is E for L Aim Public Company Limited worth?
The market values E for L Aim Public Company Limited at about 400M THB (market capitalisation, as of Nov 7, 2026). Per share that is 0.1000 THB; our models calculate a fair value of 0.2400 THB per share.
What do the bullish and bearish scenarios say about EFORL?
Our models span a range for E for L Aim Public Company Limited: cautious scenario 0.1800 THB, base 0.2400 THB, optimistic 0.3100 THB per share (as of Nov 7, 2026, price 0.1000 THB). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of EFORL?
E for L Aim Public Company Limited trades at a price-to-earnings ratio of 10.0 (as of Nov 7, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 0.2400 THB is built from several models across several years. Other multiples: P/B 0.7, P/S 0.3, EV/EBITDA 5.3.
How solid is the balance sheet of E for L Aim Public Company Limited (EFORL)?
Balance-sheet figures for E for L Aim Public Company Limited (as of Nov 7, 2026): return on equity 7.4%, debt of 0.22 per unit of equity. They feed the Quality Score of 61/100, which measures business quality independently of the share price.
How far is EFORL from its 52-week high?
E for L Aim Public Company Limited trades at 0.1000 THB, about 38% below its 52-week high of 0.1600 THB and 11% above the low of 0.0900 THB (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 0.2400 THB is for.
Which stocks are comparable to E for L Aim Public Company Limited?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is E for L Aim Public Company Limited stock attractive at the current price?
The data as of Nov 7, 2026: price 0.1000 THB, calculated fair value 0.2400 THB (+140%), Quality Score 61/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of EFORL calculated?
We run E for L Aim Public Company Limited through 22 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 0.2400 THB builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. E for L Aim Public Company Limited currently trades 58% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of E for L Aim Public Company Limited (EFORL)?
The closing price on Nov 9, 2026 was 0.1000 THB. Our model-based fair value is 0.2400 THB, about +140% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with E for L Aim Public Company Limited right now?
The price is below even our cautious bear case (0.1800 THB). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (61/100) at a price below fair value, the discount is the argument here, not the business quality.
Where does the earnings growth of E for L Aim Public Company Limited (EFORL) come from?
Earnings per share at E for L Aim Public Company Limited grew −30.3 % a year from 2014 to 2025. Broken into its drivers: revenue per share −19.6 %, EBIT margin −10.3 %, tax rate +3.0 %, residual (interest, one-offs) −6.2 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of E for L Aim Public Company Limited

How large is the market capitalisation of E for L Aim Public Company Limited (EFORL)?
The market capitalisation of E for L Aim Public Company Limited is 400M THB (≈ $12.0M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of E for L Aim Public Company Limited (EFORL)?
The price-to-sales ratio of E for L Aim Public Company Limited is 0.34 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of E for L Aim Public Company Limited (EFORL)?
Earnings per share at E for L Aim Public Company Limited are 0.0100 THB (price ÷ EPS = P/E 10.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of E for L Aim Public Company Limited (EFORL)?
The net margin of E for L Aim Public Company Limited is 3.6% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of E for L Aim Public Company Limited (EFORL)?
The return on equity (ROE) of E for L Aim Public Company Limited is 7.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of E for L Aim Public Company Limited (EFORL)?
On an EBIT basis the return on assets of E for L Aim Public Company Limited is 6.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of E for L Aim Public Company Limited (EFORL)?
The operating margin of E for L Aim Public Company Limited is 5.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at E for L Aim Public Company Limited (EFORL)?
Revenue at E for L Aim Public Company Limited is growing −28.4% versus a year earlier (3y avg −4.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at E for L Aim Public Company Limited (EFORL)?
Earnings per share at E for L Aim Public Company Limited are growing −47.9% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does E for L Aim Public Company Limited (EFORL) carry?
The net debt of E for L Aim Public Company Limited is 277M THB (fiscal year 2025, ≈ 2.8 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch E for L Aim Public Company Limited in the live analysis

One click puts E for L Aim Public Company Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.